Startseite Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study.
|

Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study.

Seite drucken
Seite teilen

Auch interessant für Sie

Neuen Wirkmechanismus von Kortison entschlüsselt

Sjögren-Tag 2024 am 6. April bei der Deutschen Rheuma-Liga Berlin

DRFZ NewsFlash abonnieren